Using the TipRanks Stock Screener Tool, we identified three companies that have low Price-to-Earnings (P/E) ratios and hold a “Strong Buy” consensus rating. Each stock also presents an upside potential of over 40% within the next year, making them compelling investment choices.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Let’s dive into the details.
Why Low P/E Stocks?
Low P/E stocks trade at a discount to their earnings, letting you buy more profit per dollar invested. This inherent margin of safety buffers against market dips and losses. While some chase high P/E names for rapid growth, history shows low P/E picks often yield better long-term returns with lower risk. They also tend to offer generous dividends, hail from established companies with steady growth, and exhibit less volatility.
CorMedix (CRMD)
- P/E Ratio: 16.4x
- Average CorMedix Price Target: $13.75 (68.5% upside)
CorMedix is a biopharmaceutical company focused on developing and selling treatments for infectious and inflammatory diseases. The company announced its Q1 2026 results today, beating estimates. CorMedix reported Q1 revenue of $127.4 million, far exceeding Wall Street’s guidance of around $105 million. Meanwhile, earnings came in at $0.43 per share, beating estimates of $0.37.
On Wall Street, CRMD stock has five Buy recommendations assigned in the last three months.
Rithm Capital (RITM)
- P/E Ratio: 12.1x
- Average Rithm Capital Price Target: $13.44 (43% upside)
Rithm Capital is a U.S.-based real estate finance company that focuses on mortgage servicing, residential loans, and asset management. RITM typically trades at a lower P/E ratio because its earnings are sensitive to interest rate changes, its mortgage and real estate business is complex to value, and its profits can swing with housing cycles and refinancing demand.
Looking ahead, RITM stock has a Strong Buy rating backed by eight Buys assigned in the last three months.
Opera (OPRA)
- P/E Ratio: 13.0x
- Average Opera Price Target: $26.50 (47.7% upside)
Opera is a technology company best known for its Opera web browser. The company mainly makes money through search partnerships, advertising, and user engagement across its browser ecosystem. Despite operating in fast-growing areas like AI and digital advertising, Opera trades at a relatively low P/E ratio compared with many tech companies. One reason is that investors see the browser market as highly competitive, with dominant players like Google’s (GOOGL) Chrome controlling a larger market share.
Looking ahead, OPRA stock has a Strong Buy rating backed by four Buys assigned in the last three months.